Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TECX Tectonic Therapeutic Inc.
- Stocks
- Healthcare
- NASDAQ: TECX
Price (delayed)
$20.71
Market cap
$386.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.14
Enterprise value
$82.51M
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
Highlights
Tectonic Therapeutic's equity has soared by 114% from the previous quarter
The EPS has surged by 81% year-on-year and by 10% since the previous quarter
Tectonic Therapeutic's quick ratio has soared by 86% from the previous quarter but it has decreased by 12% YoY
TECX's net income is down by 35% year-on-year
Key stats
What are the main financial stats of TECX
Market
Valuations
Earnings
Shares outstanding
18.67M
Market cap
$386.71M
Enterprise value
$82.51M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.28
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$63.35M
Net income
-$58.67M
EBIT
-$58.57M
EBITDA
-$55.94M
Free cash flow
-$64.78M
Per share
Balance sheet
Liquidity
EPS
-$6.14
EPS diluted
-$6.14
Free cash flow per share
-$3.78
Book value per share
$16.13
Revenue per share
$0
TBVPS
$18.35
Total assets
$314.83M
Total liabilities
$13.79M
Debt
$2.63M
Equity
$301.04M
Working capital
$296.13M
Debt to equity
0.01
Current ratio
22.92
Quick ratio
22.71
Net debt/EBITDA
5.44
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-28.3%
Return on equity
-30.9%
Return on invested capital
N/A
Return on capital employed
-19.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TECX stock price
How has the Tectonic Therapeutic stock price performed over time
Intraday
4.81%
1 week
-3.18%
1 month
28.16%
1 year
40.31%
YTD
-55.14%
QTD
16.94%
Financial performance
How have Tectonic Therapeutic's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$63.35M
Net income
-$58.67M
Gross margin
N/A
Net margin
N/A
TECX's operating income is down by 47% year-on-year and by 9% since the previous quarter
TECX's net income is down by 35% year-on-year
Price vs fundamentals
How does TECX's price correlate with its fundamentals
Growth
What is Tectonic Therapeutic's growth rate over time
Valuation
What is Tectonic Therapeutic stock price valuation
P/E
N/A
P/B
1.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 81% year-on-year and by 10% since the previous quarter
Tectonic Therapeutic's equity has soared by 114% from the previous quarter
TECX's price to book (P/B) is 44% less than its last 4 quarters average of 2.3 and 9% less than its 5-year quarterly average of 1.4
Efficiency
How efficient is Tectonic Therapeutic business performance
Tectonic Therapeutic's ROE has soared by 59% YoY and by 27% from the previous quarter
The return on assets has increased by 39% year-on-year and by 26% since the previous quarter
Dividends
What is TECX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TECX.
Financial health
How did Tectonic Therapeutic financials performed over time
The total assets has surged by 106% since the previous quarter
Tectonic Therapeutic's quick ratio has soared by 86% from the previous quarter but it has decreased by 12% YoY
TECX's debt is 99% smaller than its equity
Tectonic Therapeutic's equity has soared by 114% from the previous quarter
The debt to equity has shrunk by 50% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.